Healio (9/20, Rhoades) reports, “Patients prescribed buprenorphine at 24 mg for opioid use disorder were more likely to remain in treatment compared with those prescribed a 16 mg dose,” researchers concluded in the findings of a 6,499-patient study published online Sept. 18 in JAMA Network Open.
Related Links:
— “Higher buprenorphine dose may keep patients in treatment longer,”Andrew Rhoades, Healio, September 20, 2023